We were invited to talk about the open efforts, which includes the GeMoA consortium as well as the Tropical Disease Initiative, at the XVI congress of the Spanish Society of Medicinal Chemistry in Valencia, Spain.
-
The GeMoA consortium, composed by four academic research groups and one company from three European countries are joining efforts with the broad aim of integrating computational and experimental approaches into an innovative platform for genome-wide characterization of the mechanism-of-action for selected chemical compounds with activity against Mycobacterium tuberculosis.
This site is powered by WordPress. Theme
inspired by codium-extend.
21 Comments